$54.61+18.98% · 3M
Moving avg
1W+16.94%
1M-2.36%
3M+18.98%
6M+1.87%
YTD-12.43%
1Y-17.68%
3Y+35.68%
5Y+35.68%
52-week range
$41.7321% of range$104.32
Company health
Value0/6
Growth3/6
Profitability1/6
Health2/6
Dividend0/6
Bull vs bear
Strengths
- Analysts see 31% upside to a $71 target
- Analyst consensus is "Buy"
- Revenue compounding 65% a year
Risks
- Currently unprofitable
- Burning free cash flow
- Highly leveraged (debt is 2.7x equity)
- More volatile than the market (beta 3.5)
Key statistics
Valuation
Market cap
$9.57B
Enterprise value
$8.83B
P/E ratio (TTM)
-26.91x
P/S ratio (TTM)
5.89x
EV/EBITDA
-65.09x
Per share & returns
EPS (TTM)
-$1.69
Dividend yield
0.00%
Beta (1Y)
3.46
30-day change
-2.36%
Trading
Volume (24h)
3.29M
Previous close
$55.69
Shares outstanding
175.20M
About Tempus AI, Inc.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
NASDAQ
Symbol
TEM
Tempus AI, Inc. is a mid-cap healthcare company in the Medical - Healthcare Information Services industry. Its shares are listed on NASDAQ (United States) and trade under the ticker TEM.
Frequently asked questions
What is Tempus AI, Inc.'s market cap?
Tempus AI, Inc. (TEM) has a market capitalization of $9.57B.
What sector is Tempus AI, Inc. in?
Tempus AI, Inc. operates in the Healthcare sector, Medical - Healthcare Information Services industry.
What exchange does TEM trade on?
TEM trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.56B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.12B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.93B cap